244 related articles for article (PubMed ID: 23010958)
1. Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.
Cao W; Li J; Hu C; Shen J; Liu X; Xu Y; Ye Z
Support Care Cancer; 2013 Feb; 21(2):475-83. PubMed ID: 23010958
[TBL] [Abstract][Full Text] [Related]
2. Comparison of differences and determinants between presence and absence of sleep disturbance in hepatocellular carcinoma patients.
Chu TL; Yu WP; Chen SC; Peng HL; Wu MJ
Cancer Nurs; 2011; 34(5):354-60. PubMed ID: 21242769
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Transarterial Chemoembolization in Treatment of Primary Hepatocellular Carcinoma Complicated With Respiratory Distress Syndrome.
Ruan JY; Lin JT; Xiong Y; Chen ZZ; Chen JH; Yu HJ
Technol Cancer Res Treat; 2020; 19():1533033820970673. PubMed ID: 33243089
[TBL] [Abstract][Full Text] [Related]
4. [Identification and validation of symptom clusters in patients with hepatocellular carcinoma].
Cho MS; Kwon IG; Kim HS; Kim K; Ryu E
J Korean Acad Nurs; 2009 Oct; 39(5):683-92. PubMed ID: 19901498
[TBL] [Abstract][Full Text] [Related]
5. Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone.
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Qual Life Res; 2007 Apr; 16(3):389-97. PubMed ID: 17111232
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma.
Kim JY; Lee JS; Oh DH; Yim YH; Lee HK
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):640-5. PubMed ID: 22395224
[TBL] [Abstract][Full Text] [Related]
7. Symptom Clusters and Impact of Fatigue and Sleep Disturbance on Symptom Experiences of Hepatoma Patients in Taiwan.
Chung MH; Wang SY; Lin CC
Cancer Nurs; 2017; 40(5):403-411. PubMed ID: 27472191
[TBL] [Abstract][Full Text] [Related]
8. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
9. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life of patients with intermediate hepatocellular carcinoma after liver resection or transcatheter arterial chemoembolization.
Xie ZR; Luo YL; Xiao FM; Liu Q; Ma Y
Asian Pac J Cancer Prev; 2015; 16(10):4451-6. PubMed ID: 26028113
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.
Molinari M; Kachura JR; Dixon E; Rajan DK; Hayeems EB; Asch MR; Benjamin MS; Sherman M; Gallinger S; Burnett B; Feld R; Chen E; Greig PD; Grant DR; Knox JJ
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):684-92. PubMed ID: 17100154
[TBL] [Abstract][Full Text] [Related]
12. [Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Jeon SH; Park KS; Kim YH; Shin YS; Kang MK; Jang BK; Chung WJ; Cho KB; Hwang JS
Korean J Gastroenterol; 2007 Sep; 50(3):176-82. PubMed ID: 17885283
[TBL] [Abstract][Full Text] [Related]
13. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and prognosis of acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma: a prospective cohort study.
Hao JF; Zhang LW; Bai JX; Li YJ; Liu JN; Zhang XL; Han JM; Li X; Jiang H; Cao N
Indian J Cancer; 2015 Feb; 51 Suppl 2():e3-8. PubMed ID: 25712839
[TBL] [Abstract][Full Text] [Related]
15. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
Wang YB; Chen MH; Yan K; Yang W; Dai Y; Yin SS
Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Cho HS; Seo JW; Kang Y; Bae EJ; Kim HJ; Chang SH; Park DJ
Clin Exp Nephrol; 2011 Oct; 15(5):714-719. PubMed ID: 21695415
[TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization.
Hinrichs JB; Hasdemir DB; Nordlohne M; Schweitzer N; Wacker F; Vogel A; Kirstein MM; Marquardt S; Rodt T
Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1559-1566. PubMed ID: 28488104
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
[TBL] [Abstract][Full Text] [Related]
20. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
